Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Tryp Thrapeutics Inc (TRYPF)

Tryp Thrapeutics Inc (TRYPF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade TRYPF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3037 +3.19%
on 09/17/21
0.4400 -28.77%
on 08/27/21
-0.0510 (-14.00%)
since 08/17/21
3-Month
0.3037 +3.19%
on 09/17/21
0.5389 -41.84%
on 08/02/21
-0.1609 (-33.92%)
since 06/17/21

Most Recent Stories

More News
Differentiated Approach in Psychedelics Boosts Confidence in Upcoming Clinical Trials for Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF)

(MENAFN - Investor Brand Network)

TRYP.CN : 0.400 (-1.23%)
TRYPF : 0.3134 (-1.85%)
Researchers Find That Encounters with 'Higher Power' May Improve Mental Health

(MENAFN - Investor Brand Network) Over the millennia, different individuals have admitted to experiencing deeply moving religious encounters, sometimes spontaneously and sometimes while under the influence...

TRYP.CN : 0.400 (-1.23%)
TRYPF : 0.3134 (-1.85%)
PsychedelicNewsBreaks Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Announces Participation in Oppenheimer Fall Healthcare Summit

(MENAFN - Investor Brand Network) Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) , a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, will be...

TRYP.CN : 0.400 (-1.23%)
TRYPF : 0.3134 (-1.85%)
Tryp Therapeutics to Present at Oppenheimer Fall Healthcare Summit

San Diego, California--(Newsfile Corp. - September 16, 2021) - (CSE: TRYP) (OTCQB: TRYPF) (""), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical...

TRYP.CN : 0.400 (-1.23%)
TRYPF : 0.3134 (-1.85%)
Study Finds Fibromyalgia May Be Caused By Antibodies

(MENAFN - Investor Brand Network) A new study conducted by researchers at King's College London, in collaboration with the Karolinksa Institute and the University of Liverpool, has found that fibromyalgia...

TRYP.CN : 0.400 (-1.23%)
TRYPF : 0.3134 (-1.85%)
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF), Innovation, Partnerships, and Leadership: A 2021 Outlook

(MENAFN - Investor Brand Network)

TRYP.CN : 0.400 (-1.23%)
TRYPF : 0.3134 (-1.85%)
DEA to Increase Psilocybin, Cannabis Production for Research Purposes

(MENAFN - Investor Brand Network) The United States Drug Enforcement Administration ("DEA") has proposed an increase in the manufacture of cannabis, cannabis extract, psilocin and psilocybin for clinical...

TRYP.CN : 0.400 (-1.23%)
TRYPF : 0.3134 (-1.85%)
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) to Share Updates on Its PFN Program Pipeline at the Upcoming H.C Wainwright 23rd Annual Global Investor Conference

(MENAFN - Investor Brand Network)

TRYP.CN : 0.400 (-1.23%)
TRYPF : 0.3134 (-1.85%)
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Completes Training for Upcoming Phase 2a Psychedelics Trial Targeting Eating Disorders

(MENAFN - Investor Brand Network)

TRYP.CN : 0.400 (-1.23%)
TRYPF : 0.3134 (-1.85%)
Newfoundland Women Report Using Psychedelics Medicinally and Hope for Legalization

(MENAFN - Investor Brand Network) Researchers have found that psilocybin, which is the hallucinogenic compound found in so-called magic mushrooms, has shown potential in treating various mental conditions...

TRYP.CN : 0.400 (-1.23%)
TRYPF : 0.3134 (-1.85%)

Key Turning Points

3rd Resistance Point 0.3540
2nd Resistance Point 0.3420
1st Resistance Point 0.3277
Last Price 0.3134
1st Support Level 0.3014
2nd Support Level 0.2894
3rd Support Level 0.2751

See More

52-Week High 1.0400
Fibonacci 61.8% 0.7587
Fibonacci 50% 0.6718
Fibonacci 38.2% 0.5850
Last Price 0.3134
52-Week Low 0.3037

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar